RNActive-derived cancer vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RNActive-derived cancer vaccine, covering 2016-08-05 to 2018-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]